Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Barrett

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|September 1, 1990
Inconsistencies in clinical decisions in obstetricsJ F Barrett, G J Jarvis, H N Macdonald, et al.
American Journal of Obstetrics and Gynecology|August 15, 2000
Fetal response to maternally administered morphineE A Kopecky, M L Ryan, J F Barrett, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 27, 2002
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureusB M Ryan, C E Mazzucco, L E Lawrence, et al.
Journal of Medicinal Chemistry|October 28, 1997
Protein structure determination using a combination of comparative modeling and NMR spectroscopy. Application to the response regulator protein, Spo0FB L Podlogar, G C Leo, P A McDonnell, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
DNA gyrase inhibitory activity of ellagic acid derivativesM A Weinder-Wells, J Altom, J Fernandez, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2001
The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analoguesL E Lawrence, P Wu, L Fan, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyraseJ J Hilliard, H M Krause, J I Bernstein, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinK P Fu, S C Lafredo, B Foleno, et al.
Journal of Medicinal Chemistry|November 5, 1997
DNA gyrase inhibitory and antimicrobial activities of some diphenic acid monohydroxamidesK A Ohemeng, B L Podlogar, V N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 1999
6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systemsR M Kanojia, W Murray, J Bernstein, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|September 1, 1990
Inconsistencies in clinical decisions in obstetricsJ F Barrett, G J Jarvis, H N Macdonald, et al.
American Journal of Obstetrics and Gynecology|August 15, 2000
Fetal response to maternally administered morphineE A Kopecky, M L Ryan, J F Barrett, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 27, 2002
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureusB M Ryan, C E Mazzucco, L E Lawrence, et al.
Journal of Medicinal Chemistry|October 28, 1997
Protein structure determination using a combination of comparative modeling and NMR spectroscopy. Application to the response regulator protein, Spo0FB L Podlogar, G C Leo, P A McDonnell, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
DNA gyrase inhibitory activity of ellagic acid derivativesM A Weinder-Wells, J Altom, J Fernandez, et al.
The Journal of Antimicrobial Chemotherapy|August 2, 2001
The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analoguesL E Lawrence, P Wu, L Fan, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyraseJ J Hilliard, H M Krause, J I Bernstein, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinK P Fu, S C Lafredo, B Foleno, et al.
Journal of Medicinal Chemistry|November 5, 1997
DNA gyrase inhibitory and antimicrobial activities of some diphenic acid monohydroxamidesK A Ohemeng, B L Podlogar, V N Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 1999
6-oxa isosteres of anacardic acids as potent inhibitors of bacterial histidine protein kinase (HPK)-mediated two-component regulatory systemsR M Kanojia, W Murray, J Bernstein, et al.
Pageof 11